We are live on ! Find out more
IBIO icon

iBio
IBIO

17 hedge funds and large institutions have $2.67M invested in iBio in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

12% more capital invested

Capital invested by funds: $2.38M → $2.67M (+$284K)

0% more funds holding

Funds holding: 17 → 17 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$93.6K
2
VKH
Virtu KCG Holdings
New York
+$39.5K
3
Citadel Advisors
Citadel Advisors
Florida
+$25K
4
TSS
Two Sigma Securities
New York
+$12.5K
5
UBS Group
UBS Group
Switzerland
+$8.32K

Top Sellers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
-$20K
2
ACP
Aveo Capital Partners
Colorado
-$6.24K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
1
Arcus Capital Partners
Georgia
$1.34M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$758K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$147K – – –
BlackRock
4
BlackRock
New York
$97K +$93.6K +45 New
S
5
SignatureFD
Georgia
$66K – – –
HighTower Advisors
6
HighTower Advisors
Illinois
$54K +$4.16K +2 +9%
VKH
7
Virtu KCG Holdings
New York
$40K +$39.5K +19 New
Bank of New York Mellon
8
Bank of New York Mellon
New York
$37K +$6.24K +3 +21%
ACP
9
Aveo Capital Partners
Colorado
$31K -$6.24K -3 -18%
Northern Trust
10
Northern Trust
Illinois
$30K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$26K +$25K +12 New
UBS Group
12
UBS Group
Switzerland
$13K +$8.32K +4 +200%
TSS
13
Two Sigma Securities
New York
$12K +$12.5K +6 New
State Street
14
State Street
Massachusetts
$5K – – –
Morgan Stanley
15
Morgan Stanley
New York
$4K – – –
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$4K – – –
UAS
17
United Asset Strategies
New York
$4K – – –
Fifth Third Bancorp
18
Fifth Third Bancorp
Ohio
$1K – – –
RJA
19
Raymond James & Associates
Florida
– -$20K -10 Closed

IBIO Hedge Fund Activity: Q1 2017 in Review

17 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2017, worth a combined $2.67M — up 12% from $2.38M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IBIO positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $93.6K. The largest seller was Raymond James & Associates, exiting entirely with an estimated $20K sold.

  • 17 institutional investors held iBio (IBIO) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $2.67M of iBio stock for Q1 2017, up 12% quarter-over-quarter.
  • 4 funds opened new iBio positions in Q1 2017 and 1 closed out, a net change of +3 holders.
  • The largest iBio buyer in Q1 2017 was BlackRock, an estimated $93.6K added.
  • The largest iBio seller in Q1 2017 was Raymond James & Associates, an estimated $20K sold.

Based on aggregated 13F filings for Q1 2017.